Reported Dec 25, 2024 · Ongoing
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm…
Provepharm Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Provepharm Inc. · 100 Springhouse Dr Ste 105 · Collegeville, PA · 19426-4709
Is this the product you have?
- Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only
- Distributed byProvepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
- Lot codes and dates
Lot #: F9026F01F9026F02Exp. Date 12/2025
- Amount recalled
- 2160 packs/5 ampules per pack = 10,800 ampules
Where it was sold
- Nationwide
Why it was recalled
Discoloration
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Provepharm Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.